Journal of the American Society of Nephrology
2006 JASN IMPACT FACTOR 7.371 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 12, 2008
Journal of the American Society of Nephrology
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007101075
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Weiner, D. E.
Right arrow Articles by Levey, A. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiner, D. E.
Right arrow Articles by Levey, A. S.

Received October 5, 2007
Accepted on January 14, 2008

CLINICAL EPIDEMIOLOGY

Uric Acid and Incident Kidney Disease in the Community

Daniel E. Weiner *1, Hocine Tighiouart {dagger}, Essam F. Elsayed *, John L. Griffith {dagger}, Deeb N. Salem {ddagger}, and Andrew S. Levey *

*Division of Nephrology, {dagger}Biostatistics Research Center, and {ddagger}Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts


1 To whom correspondence should be addressed. E-mail: dweiner{at}tufts-nemc.org.


   Abstract

Uric acid may mediate aspects of the relationship between hypertension and kidney disease via renal vasoconstriction and systemic hypertension. To investigate the relationship between uric acid and subsequent reduced kidney function, limited-access data of 13,338 participants with intact kidney function in two community-based cohorts, the Atherosclerosis Risks in Communities and the Cardiovascular Health Study, were pooled. Mean baseline serum uric acid was 5.9 ± 1.5 mg/dl, mean baseline serum creatinine was 0.9 ± 0.2 mg/dl, and mean baseline estimated GFR was 90.4 ± 19.4 ml/min/1.73 m2. During 8.5 ± 0.9 yr of follow-up, 712 (5.6%) had incident kidney disease defined by GFR decrease (≥15 ml/min/1.73 m2 with final GFR <60 ml/min/1.73 m2), while 302 (2.3%) individuals had incident kidney disease defined by creatinine increase (≥0.4 mg/dl with final serum creatinine >1.4 mg/dl in men and 1.2 mg/dl in women). In GFR- and creatinine-based logistic regression models, baseline uric acid level was associated with increased risk for incident kidney disease (odds ratio 1.07 [95% confidence interval 1.01 to 1.14] and 1.11 [95% confidence interval 1.02 to 1.21] per 1-mg/dl increase in uric acid, respectively), after adjustment for age, gender, race, diabetes, systolic BP, hypertension, cardiovascular disease, left ventricular hypertrophy, smoking, alcohol use, education, lipids, albumin, hematocrit, baseline kidney function and cohort; therefore, elevated serum uric acid level is a modest, independent risk factor for incident kidney disease in the general population.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP